Interim Report Q1 2020-01-01 - 2020-03-31
The Board and Chief Executive Officer of Cereno Scientific AB here with present the Interim Report for the first quarter 2020.Summary of the Interim Report Cereno Scientific Group (2020-01-01 – 2020-03-31) · Net Sales were 0 SEK. · Loss after financial items was SEK -3,752,667. · Loss per share was SEK -0.09 before dilution and SEK -0.09after dilution*. · The equity/assets ratio was 93.8 %. Parent company Three months (1 January 2020 – 31 March 2020) · Net sales were SEK 0 (0). · Loss after financial items was SEK -3,753,523 (-5,333,633). · Loss per